Furthermore, we can increase functional verification related to SUMO binding and study the effect of SUMOylation of SUMO3 and SEH1L on cell function, thereby providing a more solid theoretical basis for the early diagnosis and treatment of PD. Here, SUMO3 is linked to Parkinson disease.